Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The market for GLP-1 drug patient support services is growing fast, and the numbers tell a clear story. Fact.MR values it at $545 million in 2026. By 2036, that figure is expected to reach $2.85 billion. That works out to…
Weight loss medicines like Wegovy have truly changed the game. For a long time, finding a lasting way to lose weight felt impossible for many of us. Now, things are different. These new treatments give people a real, science-backed chance…
Obesity is a complex health challenge that affects millions of people across the country. For a long time, traditional weight loss methods often fell short of what patients truly needed. Today, the medical landscape looks entirely different thanks to a…
Medicaid coverage for GLP-1 drugs depends heavily on where you live. That’s the frustrating truth many beneficiaries discover once they start asking questions about Ozempic, Wegovy, Mounjaro, or Zepbound. These medications first earned FDA approval for type 2 diabetes. Semaglutide…
A new study shows that starting weight loss drugs can lead to some pretty big changes in a woman’s social and work life. Researchers looked closely at women using GLP-1 medications, which include well-known names like Wegovy, Ozempic, and Mounjaro.…
Americans spent $5.7 trillion on healthcare in 2025. That figure alone is staggering. Moreover, it represents a 7.3% jump from 2024, amounting to nearly $16,500 per person. Now, federal projections confirm the country will cross the $6 trillion mark in…
A new obesity drug is getting a lot of attention, and for good reason. In a large clinical trial, people who took mazdutide lost more than 16% of their body weight in about a year. That is a significant number,…
Something interesting just came out of a clinical trial, and it is worth paying attention to. A twice-daily pill called aleniglipron helped overweight adults lose nearly 15% of their body weight. That is almost exactly what the popular weight loss…
There is no denying that GLP-1 medications have completely transformed the modern approach to metabolic health. Drugs like Wegovy, Ozempic, and Mounjaro are giving millions of people new hope for managing obesity and type 2 diabetes. These treatments are highly…
A powerful new weight loss drug is generating serious attention in medical circles. Retatrutide, developed by Eli Lilly, helped clinical trial participants lose roughly 28 percent of their body weight over 80 weeks at the highest tested dose. That translates…